Aurobindo Pharma Limited is an Indian multinational pharmaceutical company headquartered in Hyderabad, Telangana, India. The company produces generic pharmaceuticals and active pharmaceutical ingredients. Aurobindo Pharma has about 20,000 employees and revenue of US$3.6 billion.
Aurobindo Pharma’s products include antibiotics, anti-retrovirals, antimalarials, cardiovascular, central nervous system, gastrointestinal, and nasal allergy products. The company has manufacturing facilities in India, the United States, Europe, and South America.
Aurobindo Pharma’s vision is to become a global leader in the generic pharmaceuticals industry. The company’s mission is to provide affordable, high-quality medicines for all.
Aurobindo Pharma’s business strategy is to focus on innovation and R&D to develop new products and improve existing ones. The company plans to expand its manufacturing and marketing capabilities in developed markets such as the United States and Europe.